Europe Gastrointestinal Drugs Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

No. of Pages: 155    |    Report Code: TIPRE00016280    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Gastrointestinal Drugs Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Gastrointestinal Drugs Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Gastrointestinal Drugs Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing prevelance of gastrointestinal diosrders creates demnad for gastrointestinal drugs
5.2 Market Opportunities
  • 5.2.1 Strategic Initiatives by Companies are likely to create ample opportunities in the coming years
5.3 Future Trends
  • 5.3.1 Increasing research investment for novel drug development and artificial intelligence-based techniques are the key trand in coming years
5.4 Impact of Drivers and Restraints

6. Europe Gastrointestinal Drugs Market Regional Analysis

6.1 Europe Gastrointestinal Drugs Market Overview
6.2 Europe Gastrointestinal Drugs Market Revenue 2017-2027 (US$ Million)
6.3 Europe Gastrointestinal Drugs Market Forecast Analysis

7. Europe Gastrointestinal Drugs Market Analysis – by Drug Class

7.1 Acid Neutralizers
  • 7.1.1 Overview
  • 7.1.2 Acid Neutralizers: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Antidiarrheal and Laxatives
  • 7.2.1 Overview
  • 7.2.2 Antidiarrheal and Laxatives: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Anti-Inflammatory Drugs
  • 7.3.1 Overview
  • 7.3.2 Anti-Inflammatory Drugs: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Antiemetic and Antinauseants
  • 7.4.1 Overview
  • 7.4.2 Antiemetic and Antinauseants: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Biologics
  • 7.5.1 Overview
  • 7.5.2 Biologics: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Gastrointestinal Drugs Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Gastrointestinal Drugs Market Analysis – by Application

9.1 Inflammatory Ulcerative Colitis
  • 9.1.1 Overview
  • 9.1.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Crohn's Disease
  • 9.2.1 Overview
  • 9.2.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Irritable Bowel Syndrome
  • 9.3.1 Overview
  • 9.3.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Gastroenteritis
  • 9.4.1 Overview
  • 9.4.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Celiac Disease
  • 9.5.1 Overview
  • 9.5.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Gastrointestinal Drugs Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Gastrointestinal Drugs Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Europe Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 UK: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.1.2 UK: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.1.3 UK: Europe Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.2 Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.2.2 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.2.3 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.3 France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 France: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.3.2 France: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.3.3 France: Europe Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.4 Russia: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.4.2 Russia: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.4.3 Russia: Europe Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.5 Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.5.2 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.5.3 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Application
  • 10.1.1.6 Rest of Europe: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
    • 10.1.1.6.2 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Route of Administration
    • 10.1.1.6.3 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Gastrointestinal Drugs Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Sanofi
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GlaxoSmithKline plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 AstraZeneca
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Bayer AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Gastrointestinal Drugs Market

The List of Companies - Europe Gastrointestinal Drugs Market

  1. Sanofi
  2. GlaxoSmithKline plc
  3. Johnson and Johnson Services, Inc.
  4. AstraZeneca
  5. Bayer AG
europe-gastrointestinal-drugs-market